Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China · Delayed Price · Currency is CNY 27.34
+0.14 (0.51%)
Oct 23, 2026, 3:00 PM CST
SHA:688076 Market Cap
SHA:688076 has a market cap or net worth of 8.66 billion as of October 22, 2026. It is the 8,770th most valuable company in the world and the 1,798th biggest in China. Its market cap has decreased by 26.33% in one year.
Market Cap
8.66B
Enterprise Value
10.55B
Revenue
2.03B
Global Rank
Country Rank
#1,798 China
PE Ratio
36.29
ChartMarket Cap Chart
Since May 20, 2021, SHA:688076's market cap has decreased from 16.52B to 8.66B, a decrease of -47.57%. That is a compound annual growth rate of -11.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 8.66B | -27.30% |
| Dec 31, 2025 | 11.92B | 4.42% |
| Dec 31, 2024 | 11.41B | 19.08% |
| Dec 29, 2023 | 9.58B | 95.95% |
| Dec 30, 2022 | 4.89B | -44.50% |
| Dec 31, 2021 | 8.81B | -46.67% |
| May 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chengzhi | 9.56B |
| Mabwell (Shanghai) Bioscience | 9.45B |
| Staidson (Beijing) BioPharmaceuticals | 9.37B |
| Pacific Shuanglin Bio-pharmacy | 8.93B |
| Chongqing Genrix Biopharmaceutical | 8.39B |
| InventisBio | 8.33B |
| Liaoning Chengda Biotechnology | 8.22B |
| Shanghai OPM Biosciences | 8.05B |